These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 21115916)
1. Inhibition of CK2{alpha} and PI3K/Akt synergistically induces apoptosis of CD34+CD38- leukaemia cells while sparing haematopoietic stem cells. Cheong JW; Min YH; Eom JI; Kim SJ; Jeung HK; Kim JS Anticancer Res; 2010 Nov; 30(11):4625-34. PubMed ID: 21115916 [TBL] [Abstract][Full Text] [Related]
2. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569 [TBL] [Abstract][Full Text] [Related]
3. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells. Zhang L; Zhou Y; Chen K; Shi P; Li Y; Deng M; Jiang Z; Wang X; Li P; Xu B Target Oncol; 2017 Oct; 12(5):677-687. PubMed ID: 28710745 [TBL] [Abstract][Full Text] [Related]
4. IL-1β inhibits self-renewal capacity of dormant CD34⁺/CD38⁻ acute myelogenous leukemia cells in vitro and in vivo. Yang J; Ikezoe T; Nishioka C; Nobumoto A; Yokoyama A Int J Cancer; 2013 Oct; 133(8):1967-81. PubMed ID: 23564444 [TBL] [Abstract][Full Text] [Related]
5. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells. Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991 [TBL] [Abstract][Full Text] [Related]
6. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells. Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of the PI3K pathway sensitizes fludarabine-induced apoptosis in human leukemic cells through an inactivation of MAPK-dependent pathway. Yu C; Mao X; Li WX Biochem Biophys Res Commun; 2005 Jun; 331(2):391-7. PubMed ID: 15850772 [TBL] [Abstract][Full Text] [Related]
8. LY294002 induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like cells from human osteosarcoma via down-regulation of PI3K activity. Gong C; Liao H; Wang J; Lin Y; Qi J; Qin L; Tian LQ; Guo FJ Asian Pac J Cancer Prev; 2012; 13(7):3103-7. PubMed ID: 22994717 [TBL] [Abstract][Full Text] [Related]
9. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission. van Rhenen A; Moshaver B; Kelder A; Feller N; Nieuwint AW; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ Leukemia; 2007 Aug; 21(8):1700-7. PubMed ID: 17525725 [TBL] [Abstract][Full Text] [Related]
10. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595 [TBL] [Abstract][Full Text] [Related]
11. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia. Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294 [TBL] [Abstract][Full Text] [Related]
12. Silencing of miR-21 sensitizes CML CD34+ stem/progenitor cells to imatinib-induced apoptosis by blocking PI3K/AKT pathway. Wang WZ; Pu QH; Lin XH; Liu MY; Wu LR; Wu QQ; Chen YH; Liao FF; Zhu JY; Jin XB Leuk Res; 2015 Oct; 39(10):1117-24. PubMed ID: 26248946 [TBL] [Abstract][Full Text] [Related]
14. Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia. Moshaver B; Wouters RF; Kelder A; Ossenkoppele GJ; Westra GAH; Kwidama Z; Rutten AR; Kaspers GJL; Zweegman S; Cloos J; Schuurhuis GJ Leuk Res; 2019 Jun; 81():27-34. PubMed ID: 31002948 [TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase expression as a potential determinant of parthenolide-induced apoptosis in leukemia bulk and leukemia stem cells. Kim YR; Eom JI; Kim SJ; Jeung HK; Cheong JW; Kim JS; Min YH J Pharmacol Exp Ther; 2010 Nov; 335(2):389-400. PubMed ID: 20699435 [TBL] [Abstract][Full Text] [Related]
16. A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor. Li Y; Chen K; Zhou Y; Xiao Y; Deng M; Jiang Z; Ye W; Wang X; Wei X; Li J; Liang J; Zheng Z; Yao Y; Wang W; Li P; Xu B Curr Cancer Drug Targets; 2015; 15(6):493-503. PubMed ID: 26282548 [TBL] [Abstract][Full Text] [Related]
17. LY294002 and LY303511 sensitize tumor cells to drug-induced apoptosis via intracellular hydrogen peroxide production independent of the phosphoinositide 3-kinase-Akt pathway. Poh TW; Pervaiz S Cancer Res; 2005 Jul; 65(14):6264-74. PubMed ID: 16024628 [TBL] [Abstract][Full Text] [Related]
18. Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells. Svensson E; Vidovic K; Lassen C; Richter J; Olofsson T; Fioretos T; Gullberg U Leukemia; 2007 Dec; 21(12):2485-94. PubMed ID: 17728783 [TBL] [Abstract][Full Text] [Related]
19. ENPP4 and HOXA3 as potential leukaemia stem cell markers in acute myeloid leukaemia. Mohd Amin A; Panneerselvan N; Md Noor S; Mohtaruddin N; Sathar J; Norbaya WS; Osman R; Kee LH; Mohd Yaakub WH; Cheong SK; Abdullah M Malays J Pathol; 2023 Apr; 45(1):65-76. PubMed ID: 37119247 [TBL] [Abstract][Full Text] [Related]
20. Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo. Budhraja A; Gao N; Zhang Z; Son YO; Cheng S; Wang X; Ding S; Hitron A; Chen G; Luo J; Shi X Mol Cancer Ther; 2012 Jan; 11(1):132-42. PubMed ID: 22084167 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]